123 related articles for article (PubMed ID: 18543137)
1. Only if needed and as minimally as possible. Animal model for post-ERCP pancreatitis: a step in the right direction.
Guda N; Freeman M
Endoscopy; 2008 Jun; 40(6):521-2. PubMed ID: 18543137
[No Abstract] [Full Text] [Related]
2. Severity of post-ERCP pancreatitis directly proportional to the invasiveness of endoscopic intervention: a pilot study in a canine model.
Buscaglia JM; Simons BW; Prosser BJ; Ruben DS; Giday SA; Magno P; Clarke JO; Shin EJ; Kalloo AN; Kantsevoy SV; Gabrielson KL; Jagannath SB
Endoscopy; 2008 Jun; 40(6):506-12. PubMed ID: 18478511
[TBL] [Abstract][Full Text] [Related]
3. Post-ERCP pancreatitis: new momentum.
Rabenstein T; Hahn EG
Endoscopy; 2002 Apr; 34(4):325-9. PubMed ID: 11932791
[No Abstract] [Full Text] [Related]
4. Risk factors for post-ERCP pancreatitis.
Kadayifci A
Endoscopy; 2008 Jan; 40(1):81; author reply 81. PubMed ID: 18210348
[No Abstract] [Full Text] [Related]
5. Is the rate of post-ERCP pancreatitis not reduced by guide-wire cannulation?
Park DH; Lee SS; Seo DW; Lee SK; Kim MH
Endoscopy; 2008 Sep; 40(9):784; author reply 785. PubMed ID: 18773344
[No Abstract] [Full Text] [Related]
6. Efficacy of recombinant human interleukin-10 in prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in subjects with increased risk.
Sherman S; Cheng CL; Costamagna G; Binmoeller KF; Puespoek A; Aithal GP; Kozarek RA; Chen YK; Van Steenbergen W; Tenner S; Freeman M; Monroe P; Geffner M; Deviere J;
Pancreas; 2009 Apr; 38(3):267-74. PubMed ID: 19214137
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic retrograde cholangiopancreatography and acute biliary pancreatitis: time for a divorce?
Mosca S
Endoscopy; 2001 Apr; 33(4):382. PubMed ID: 11315904
[No Abstract] [Full Text] [Related]
8. Etanercept, a TNF-alpha binding agent, is ineffective in the prevention of post-ERCP pancreatitis in canines.
Buscaglia JM; Simons BW; Prosser BJ; Ruben DS; Giday SA; Magno P; Clarke JO; Shin EJ; Kalloo AN; Kantsevoy SV; Gabrielson KL; Jagannath SB
JOP; 2008 Jul; 9(4):456-67. PubMed ID: 18648137
[TBL] [Abstract][Full Text] [Related]
9. Quality indicators, including complications, of ERCP in a community setting: a prospective study.
Colton JB; Curran CC
Gastrointest Endosc; 2009 Sep; 70(3):457-67. PubMed ID: 19482278
[TBL] [Abstract][Full Text] [Related]
10. Incidence, risk factors, and prevention of post-ERCP pancreatitis.
Cooper ST; Slivka A
Gastroenterol Clin North Am; 2007 Jun; 36(2):259-76, vii-viii. PubMed ID: 17533078
[TBL] [Abstract][Full Text] [Related]
11. [Endoscopic retrograde cholangiopancreatography: is it possible to effectively prevent ERCP-induced pancreatitis?].
Il'chenko AA
Eksp Klin Gastroenterol; 2008; (3):62-71. PubMed ID: 19145885
[No Abstract] [Full Text] [Related]
12. Evaluation of recombinant platelet-activating factor acetylhydrolase for reducing the incidence and severity of post-ERCP acute pancreatitis.
Sherman S; Alazmi WM; Lehman GA; Geenen JE; Chuttani R; Kozarek RA; Welch WD; Souza S; Pribble J;
Gastrointest Endosc; 2009 Mar; 69(3 Pt 1):462-72. PubMed ID: 19231487
[TBL] [Abstract][Full Text] [Related]
13. Does obesity confer an increased risk and/or more severe course of post-ERCP pancreatitis?: a retrospective, multicenter study.
Deenadayalu VP; Blaut U; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Temkit M; Lehman GA; Sherman S
J Clin Gastroenterol; 2008; 42(10):1103-9. PubMed ID: 18936645
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic therapy of recurrent acute pancreatitis.
Parsi MA; Stevens T; Dumot JA; Zuccaro G
Cleve Clin J Med; 2009 Apr; 76(4):225-33. PubMed ID: 19339638
[TBL] [Abstract][Full Text] [Related]
15. ERCP and biliary topics.
Dumonceau JM
Endoscopy; 2006 Jan; 38(1):11-5. PubMed ID: 16429348
[No Abstract] [Full Text] [Related]
16. Severe gallstone pancreatitis.
Lee SK; Kim MH; Seo DW
Endoscopy; 2001 Apr; 33(4):382-4. PubMed ID: 11315905
[No Abstract] [Full Text] [Related]
17. Myocardial ischemia, pancreatitis and ERCP.
Roberts-Thomson IC; Teo E; Roberts-Thomson KC
J Gastroenterol Hepatol; 2010 Sep; 25(9):1469-70. PubMed ID: 20796138
[No Abstract] [Full Text] [Related]
18. The Prevention, recognition and treatment of post-ERCP pancreatitis.
Badalov N; Tenner S; Baillie J
JOP; 2009 Mar; 10(2):88-97. PubMed ID: 19287099
[No Abstract] [Full Text] [Related]
19. Antiproteasic agents in the prevention of post-ERCP pancreatitis: rationale for use and clinical results.
Cavallini G; Frulloni L
JOP; 2003 Jan; 4(1):75-82. PubMed ID: 12555019
[No Abstract] [Full Text] [Related]
20. 30 years of ERCP and still the same problems?
Guda NM; Freeman ML
Endoscopy; 2007 Sep; 39(9):833-5. PubMed ID: 17703395
[No Abstract] [Full Text] [Related]
[Next] [New Search]
